Anticancer Peptide Market Offers US$ 18 Billion Opportunity Says Kuick Research. Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The ...
Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.